Practical Guidance on Biosimilars, With a Focus on Latin America
| Autor: | Heather Jones, Alejandra Babini, Cecilia Borlenghi, Carlo V. Caballero-Uribe, Valderílio Feijó Azevedo, Gilberto Castañeda-Hernández |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
030203 arthritis & rheumatology
medicine.medical_specialty Latin Americans business.industry MEDLINE Biosimilar medicine.disease 03 medical and health sciences Biologic Products 0302 clinical medicine Rheumatology Need to know Rheumatoid arthritis medicine Cost of treatment 030212 general & internal medicine Intensive care medicine business Antirheumatic drugs |
| Zdroj: | JCR: Journal of Clinical Rheumatology. 25:91-100 |
| ISSN: | 1076-1608 |
| Popis: | Background/Historical PerspectiveAvailability of biologic disease-modifying antirheumatic drugs (bDMARDs) has improved clinical outcomes in rheumatoid arthritis, but it also increased the cost of treatment. Biosimilars, the regulated copies of biologic products, have a potential to reduce health car |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|